Capital Research Global Investors 13D/13G Filings for Abbott Laboratories (ABT)

Capital Research Global Investors 13D and 13G filings for Abbott Laboratories:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
3:46 pm
Sale
2021-02-16 13G Abbott Laboratories
ABT
Capital Research Global Investors 86,394,199
4.900%
-27,295,094decrease
(-24.01%)
Filing